期刊文献+

血浆纤维蛋白原水平在卵巢肿瘤临床诊断中的作用 被引量:3

Application of fibrinogen detection in the clinical diagnosis of ovarian tumors
原文传递
导出
摘要 目的探讨血浆纤维蛋白原(FIB)水平在卵巢肿瘤临床诊断中的价值。方法选择2012年3月至2013年9月间诊治的120例原发上皮性卵巢癌患者为观察组,100例卵巢良性肿瘤患者为对照组。分析两组患者的血浆FIB水平,以及不同分期的原发上皮性卵巢癌患者血浆FIB水平、和不同临床病理因素的原发性卵巢上皮癌患者血浆FIB水平。结果观察组患者血浆FIB水平增高的发生率为40.0%,对照组为7.0%,差异有统计学意义(2=7.81,P=0.028)。不同分期的原发上皮性卵巢癌患者血浆FIB水平之间差异有统计学意义(P<0.05)。随着原发上皮性卵巢癌分期的升高,血浆FIB水平增高的发生率也增加(2=6.98,P=0.041)。早期(Ⅰ、Ⅱ期)和晚期(Ⅲ、Ⅳ期)原发上皮性卵巢癌患者的血浆FIB水平之间差异有统计学意义(t=7.21,P=0.036)。不同组织学分级和不同腹水量患者的血浆FIB水平增高的差异无统计学意义(P>0.05),但在术后残留病灶>2 cm的患者中,血浆FIB增高的发生率高于≤2 cm者,差异有统计学意义(2=7.60,P=0.031)。结论血浆FIB水平对于原发上皮性卵巢癌患者的病情诊断和评估有一定的价值。 Objective To explore application value of plasma fibrinogen (FIB) detection in the clinical diagnosis of ovarian tumors. Methods A total of 120 patients with primary epithelial ovarian cancer were choosen from Armed Police Corps Hospital of He' nan as the observation group, 100 patients with benign ovarian tumors as the control group. Comparative analysis of plasma FIB level of two groups of patients, plasma FIB level of primary epithelial ovarian cancer in different stages, plasma FIB level of primary epithelial ovarian cancer early (Ⅰ, Ⅱ period) and late (Ⅲ, Ⅳ period) stage and plasma FIB level of various clinicopathological factors of primary epithelial ovarian cancer. Results In the observation group, patients had elevated plasma FIB level of 40. 0%, and 7. 0% in the control group, the difference was statistically significant (x^2 =7. 81, P=0.028). Differences in plasma FIB level of primary epithelial ovarian cancer between the various stages was statistically significant (P 〈0. 05). With the increase of primary epithelial ovarian cancer staging, patients with increased levels of plasma FIB ratio also increased (x^2 = 6. 98, P = 0. 041 ) . The differences of plasma FIB level between primary epithelial ovarian cancer early ( Ⅰ , Ⅱ period) and late ( Ⅲ, Ⅳ period) stage was statistically significant (t =7. 21, P =0. 036). The differences of increased plasma FIB level in different histological grade and different amount of ascites were no significant (P 〉 0.05 ) , but in the swollen postoperative residual lesions 〉 2 cm patient ratio is higher than 42 cm, and the difference was statistically significant ( x^2 = 7.60, P = 0. 031 ). Conclusion Monitoring plasma FIB level have a clinical value for diagnosis and assessment of patients with primary epithelial ovarian cancer.
出处 《中国肿瘤临床与康复》 2014年第12期1476-1478,共3页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 卵巢肿瘤 血浆纤维蛋白原 病理分期 Ovarian neoplasms Plasma fibrinogen Pathological stage
  • 相关文献

参考文献13

二级参考文献95

  • 1李墨林,蔡桂凤,朱敏,郑军,舒晓宏,李明霞.卵巢恶性肿瘤患者血浆纤维蛋白原及血小板四项参数检测的临床意义[J].大连医科大学学报,2004,26(4):280-283. 被引量:3
  • 2程蓓,俞黎铭,叶大风.上皮性卵巢癌患者凝血功能测定及其临床意义[J].浙江医学,2005,27(7):490-492. 被引量:14
  • 3王琼,谢嵘,张青云.结直肠癌患者血浆纤维蛋白原的检测及其临床意义[J].中华肿瘤杂志,2005,27(9):544-546. 被引量:36
  • 4于颖,王志平.血浆D-二聚体与恶性肿瘤的关系[J].实用医技杂志,2006,13(21):3874-3876. 被引量:8
  • 5Augusto P, Javier FM, Victoria R, et al. Pelvic and aortic lymph node metastasis in epithelial ovarian cancer [ J ]. Gynecol Oncol 2007,105:604 - 608.
  • 6du Bois A, Reuss A, Harter P, et al. Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospect ely randomized phase Ⅲ multicenter trials[ J ]. J Clin Oncol, 2010,28(10) :1733 - 1739.
  • 7Timmers PJ, Zwinderman AH, Coens C, et al. Understanding the problem of inadequately staging early ovarian cancer[J]. Eur J Cancer,2010, 46(5) :880 -884.
  • 8Zanetta G, Rota S, Chiari S, et al. The accuracy of staging: an important prognostic determinator in stage l ovarian carcinoma[J]. Annals of Oncology, 1998,9 : 1097 - 1101.
  • 9Heintz A, Odicino F, Maisnneuve P, et al. Carcinoma of the ovary 25^th annual report on the results of treatment of gynecological cancer [J]. Int J Gynecol Obstet, 2003,83( 1 ) :135 - 166.
  • 10Edgar P, Hans-Joachim L, Gavin S, et al. Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system [ J ]. European Journal of Obstetrics & Gynecology and Reproducte Biology ,2009,143 ( 1 ) :69 - 74.

共引文献57

同被引文献17

  • 1李春颖,吴鸣,原劲阳.血小板及纤维蛋白原对卵巢癌患者病情进展的影响[J].中国医学科学院学报,2009,31(1):81-83. 被引量:7
  • 2Alcdzar JL, Royo P, Jurado M, et al. Triage for surgical manage- ment of ovarian tumors in asymptomatic women : assessment of an ultrasound-based scoring system [ J]. Ultrasound Obstet Gyne- col, 2008, 32:220-225.
  • 3Ciledag N, Arda K, Aktas E, et al. A pilot study on real-time transvaginal uhrasonographic elastrograph of cystic ovarian le- sions[ J]. Indian J Med Res, 2013, 137:1089-1092.
  • 4Majeed H, Ramzan A, Imran F, et al. Validity of resistive index for the diagnosis of malignant ovarian masses[ J]. J Pak Med As- soc, 2011, 61:1104-1107.
  • 5Jemal A, Bray F, Melissa M, et al. Global Cancer Statistic [ J]. Cancer J Clin, 2011,61 : 69-90.
  • 6Agachan Cakmakoglu B, Attar R, Kahraman OT, et al. Cy- clooxygenase-2 gene and epithelial ovarian carcinoma risk [ J ]. Mol Biol Rep, 2011, 38:3481-3486.
  • 7Lin Y, Cui M, Xu T, et al. Silencing of cyclooxygenase- 2 in- hibits the growth, invasion and migration of ovarian cancer cells [J]. Mol Med Rep, 2014, 9:2499-2504.
  • 8Mouradian M, Kikawa KD, Johnson ED, et al. Key roles for GRB2- associated- binding protein 1, phosphatidylinositol- 3- ki- nase, cyclooxygenase 2, prostaglandin E2 and transforming growth factor alpha in linoleic acid- induced upregulation of lung and breast cancer cell growth[ J ]. Prostaglandins Leukot Essent Fatty Acids, 2014, 90:105-115.
  • 9Hu S, Sun W, Wei W, et al. Involvement of the prostaglandin E receptor EP2 in paeoniflorin- induced human hepatoma cell apoptosis[ J]. Anticancer Drugs, 2013, 24:140-149.
  • 10沈惠芬.经阴道二维及彩色多普勒超声对多囊卵巢综合征的诊断价值[J].当代医学,2012,18(14):91-91. 被引量:8

引证文献3

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部